The Economic Times

Motilal Oswal sees Aster DM EBITDA rising 25% CAGR through FY28; sets Rs 910 target

Motilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and Rs 910 target, citing merger synergies, capacity expansion and improving operating metrics. The brokerage expects revenue, EBITDA and PAT to grow at CAGRs of 19.5%, 25% and 33%, respectively, through FY28.